Literature DB >> 24965963

Resistant hypertension in diabetes mellitus.

George Bayliss1, Larry A Weinrauch, John A D'Elia.   

Abstract

Resistant hypertension in diabetes is associated with poor cardiovascular and renal outcomes. This brief review will examine the definitions and epidemiology of resistant hypertension and consider the differences between apparent resistant hypertension and truly resistant or refractory hypertension. It will review the role of the sympathetic nervous system in resistant hypertension. It will consider the relationship between obesity and leptin resistance and sympathetic signaling; the role of obstructive sleep apnea in resistant hypertension; and the role of aldosterone in resistant hypertension. It will conclude by mentioning briefly renal nerve ablation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24965963     DOI: 10.1007/s11892-014-0516-y

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  58 in total

1.  Antihypertensive treatment and resistant hypertension in patients with type 1 diabetes by stages of diabetic nephropathy.

Authors:  Raija Lithovius; Valma Harjutsalo; Carol Forsblom; Markku Saraheimo; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2013-10-29       Impact factor: 19.112

2.  Neurogenic control of renal tubular sodium reabsorption in the dog: a brief review and preliminary report concerning possible humoral mediation.

Authors:  G F DiBona; E J Zambraski; A J Aguilera; G J Kaloyanides
Journal:  Circ Res       Date:  1977-05       Impact factor: 17.367

3.  Systemic and renal-specific sympathoinhibition in obesity hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu; Boshen Liu; Jeffrey R Henegar; Christine Maric-Bilkan; Eric D Irwin
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

4.  Role of selective leptin resistance in diet-induced obesity hypertension.

Authors:  Kamal Rahmouni; Donald A Morgan; Gina M Morgan; Allyn L Mark; William G Haynes
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

5.  Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

Authors:  Henry Krum; Markus P Schlaich; Paul A Sobotka; Michael Böhm; Felix Mahfoud; Krishna Rocha-Singh; Richard Katholi; Murray D Esler
Journal:  Lancet       Date:  2013-11-07       Impact factor: 79.321

6.  Blunted sympathoinhibitory responses in obesity-related hypertension are due to aberrant central but not peripheral signalling mechanisms.

Authors:  Jackie M Y How; Suhail A Wardak; Shaik I Ameer; Rachel A Davey; Daniela M Sartor
Journal:  J Physiol       Date:  2014-02-03       Impact factor: 5.182

7.  The contributions of unhealthy lifestyle factors to apparent resistant hypertension: findings from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Daichi Shimbo; Emily B Levitan; John N Booth; David A Calhoun; Suzanne E Judd; Daniel T Lackland; Monika M Safford; Suzanne Oparil; Paul Muntner
Journal:  J Hypertens       Date:  2013-02       Impact factor: 4.844

8.  Primary aldosteronism in diabetic subjects with resistant hypertension.

Authors:  Guillermo E Umpierrez; Paul Cantey; Dawn Smiley; Andres Palacio; Diana Temponi; Karen Luster; Arlene Chapman
Journal:  Diabetes Care       Date:  2007-04-11       Impact factor: 19.112

9.  The severity of nocturnal hypoxia but not abdominal adiposity is associated with insulin resistance in non-obese men with sleep apnea.

Authors:  Anne-Laure Borel; Denis Monneret; Renaud Tamisier; Jean-Philippe Baguet; Patrice Faure; Patrick Levy; Serge Halimi; Jean-Louis Pépin
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 10.  The autonomic nervous system and renal physiology.

Authors:  John A D'Elia; Larry A Weinrauch
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.